Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 2, 2021
Patent Application Number
16872225
Date Filed
May 11, 2020
Patent Citations
Patent Citations Received
0
...
Patent Primary Examiner
Patent abstract
This invention provides heterocyclic compounds that bind to E3 Ubiquitin Ligase (typically through cereblon) (“Degrons”), which can be used as is or linked to a Targeting Ligand for a selected Target Protein for therapeutic purposes and methods of use and compositions thereof as well as methods for their preparation.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
